Navigation Links
Scripps researchers recommend mobile compression device to prevent DVT after joint surgery
Date:2/14/2014

LA JOLLA, Calif. Research from The Shiley Center for Orthopaedic Research and Education at Scripps Clinic could change how patients are treated to prevent blood clots after joint replacement surgery. A study published as the lead article in the current issue of the Journal of Bone and Joint Surgery determined that after lower extremity joint replacement surgery a mobile compression device was just as effective as blood thinners in preventing deep vein thrombosis (DVT), but without negative side effects including bleeding complications.

The multicenter study, led by Scripps Clinic orthopedic surgeon Clifford Colwell, M.D., evaluated the efficacy of a mobile compression device that is small and portable enough for patients to use at home for 10 days or longer after joint replacement surgery.

"Blood thinners have long been considered the standard of care to prevent blood clots after orthopedic surgery, but they can have side effects that are concerning for many patients," said Dr. Colwell. "Through this research we have found and established an equally effective means of accomplishing the same goal with an added layer of safety for patients."

From April 1 to Sept. 20, 2011, 10 medical centers in the United States participated in a registry to collect data on the occurrence of DVT in 3,000 patients who used the mobile compression device after surgery. The rate of DVT in patients who used the compression device was consistent with the rate of DVT in similar patient populations who were prescribed blood thinners, which is approximately 1 percent.

The device used during the study was the ActiveCare+S.F.T., which works by delivering compressions to the leg that coordinate with a patients respiration rate thereby improving blood flow. The manufacturer of the device funded the registry used in the study but did not have any role in the development of the registry design or protocol. The authors did not receive compensation for their role in the study.


'/>"/>

Contact: Kristin Reinhardt
reinhardt.kristin@scrippshealth.org
619-565-7038
Scripps Health
Source:Eurekalert

Related medicine news :

1. Scripps Research scientists show how memory B cells stay in class to fight different infections
2. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
3. Clinical trials start for stroke drug developed by Scripps Research, USC, and ZZ Biotech
4. Scripps Research scientists devise powerful new method for finding therapeutic antibodies
5. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
6. Scripps Research Institute receives $20 million to shed light on HIV drug resistance
7. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
8. 2 Scripps Research Institute scientists honored by American Chemical Society
9. Scripps Research Institute study points to potential new therapies for cancer and other diseases
10. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
11. Scripps Florida scientist awarded $2.5 million to study inner workings of memory formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has issued an important reminder to employers to ... Employers with workers exposed to high temperatures should establish a complete heat ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: